Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

1. Usmani, S.Z.
2. Mateos, M.-V.
3. Hungria, V.
4. Iida, S.
5. Bahlis, N.J.
6. Nahi, H.
7. Magen, H.
8. Cavo, M.
9. Hulin, C.
10. White, D.
11. De Stefano, V.
12. Fastenau, J.
13. Slavcev, M.
14. Heuck, C.
15. Qin, X.
16. Pei, H.
17. Masterson, T.
18. Lantz, K.
19. Gries, K.S.